Close

BCMA-2

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

BCMA protein is often overexpressed in multiple myeloma.
  • CAR Cell Products

Loading...
  • Host Cell Type:
  • Target:
  • CAR Construction:
CAT Product Name Host Cell Type Target scFv Clone CAR Construction CAR Cell Type Inquiry & Datasheet
CARJ-LX032 Anti-BCMA-2 h(TM28-CD28-CD3ζ) CAR, Jurkat Cell T lymphocyte BCMA-2 scFv-TM28-CD28-CD3ζ   Add to Cart   Datasheet
CARJ-LX050 Anti-BCMA-2 h(TM-CD28-CD3ζ) CAR, Jurkat Cell T lymphocyte BCMA-2 scFv-TM-CD28-CD3ζ   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.